Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis

David Adams, Alejandra Gonzalez-Duarte, William D. O'Riordan, Chih Chao Yang, Mitsuharu Ueda, Arnt V. Kristen, Ivailo Tournev, Hartmut H. Schmidt, Teresa Coelho, John L. Berk, Kon Ping Lin, Giuseppe Vita, Shahram Attarian, Violaine Planté-Bordeneuve, Michelle M. Mezei, Josep M. Campistol, Juan Buades, Thomas H. Brannagan, Byoung J. Kim, Jeeyoung OhYesim Parman, Yoshiki Sekijima, Philip N. Hawkins, Scott D. Solomon, Michael Polydefkis, Peter J. Dyck, Pritesh J. Gandhi, Sunita Goyal, Jihong Chen, Andrew L. Strahs, Saraswathy V. Nochur, Marianne T. Sweetser, Pushkal P. Garg, Akshay K. Vaishnaw, Jared A. Gollob, Ole B. Suhr

Research output: Contribution to journal › Article › peer-review

797 Scopus citations

Fingerprint

Dive into the research topics of 'Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis'. Together they form a unique fingerprint.

Medicine & Life Sciences